The Human Genome Organisation (HUGO) and the 2020 COVID-19 pandemic
Open Access
- 10 February 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Human Genomics
- Vol. 15 (1), 1-3
- https://doi.org/10.1186/s40246-021-00310-x
Abstract
This letter is the Human Genome Organisation’s summary reaction to the 2020 COVID-19 pandemic. It identifies key areas for genomics research, and areas in which genomic scientists can contribute to a global response to the pandemic. The letter has been reviewed and endorsed by the HUGO Committee on Ethics, Law and Society (CELS) and the HUGO Council.Keywords
This publication has 21 references indexed in Scilit:
- A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19Annals of Internal Medicine, 2020
- Two elite medical journals retract coronavirus papers over data integrity questionsScience, 2020
- Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and InfluenzaCell, 2020
- CRISPR–Cas12-based detection of SARS-CoV-2Nature Biotechnology, 2020
- Pathogen Genomics in Public HealthThe New England Journal of Medicine, 2019
- The Multilevel Regulation of Complex Policy Problems: Uncertainty and the Swine Flu PandemicEuropean Policy Analysis, 2019
- ASHG Denounces Attempts to Link Genetics and Racial SupremacyAmerican Journal of Human Genetics, 2018
- Pandemics: spend on surveillance, not predictionNature, 2018
- Ethical issues of CRISPR technology and gene editing through the lens of solidarityBritish Medical Bulletin, 2017
- Introducing One Health to the Ethical Debate About Zoonotic Diseases in Southeast AsiaBioethics, 2015